{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:07:08Z","timestamp":1789178828151,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology Nursing"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.soncn.2022.151249","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:54:09Z","timestamp":1645664049000},"page":"151249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Clinical Updates in Nausea and Vomiting"],"prefix":"10.1016","volume":"38","author":[{"given":"Diane G.","family":"Cope","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.soncn.2022.151249_bib0001","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/annonc\/mdx100","article-title":"The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting","volume":"28","author":"Dranitsaris","year":"2017","journal-title":"Ann Oncol."},{"key":"10.1016\/j.soncn.2022.151249_bib0002","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.critrevonc.2015.12.001","article-title":"Impact of chemotherapy-induced nausea and vomiting on health-related quality of life and resource utilization: a systematic review","volume":"99","author":"Sommariva","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"suppl 6","key":"10.1016\/j.soncn.2022.151249_bib0003","first-page":"1","article-title":"Chemotherapy induced nausea and vomiting and quality of life of patients on moderate and highly emetogenic chemotherapy","volume":"30","author":"Mahidin","year":"2019","journal-title":"Ann Oncol."},{"issue":"12","key":"10.1016\/j.soncn.2022.151249_bib0004","first-page":"e12038","article-title":"Breast cancer patients\u2019 perceptions of their experience with chemotherapy-induced nausea and vomiting and its impact on quality of life in Jeddah, Saudi Arabia","volume":"12","author":"Ilyas","year":"2020","journal-title":"Cureus"},{"issue":"115","key":"10.1016\/j.soncn.2022.151249_bib0005","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.7314\/APJCP.2015.16.15.6207","article-title":"Prevention of chemotherapy-induced nausea and vomiting in cancer patients","volume":"16","author":"Shankar","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"issue":"14","key":"10.1016\/j.soncn.2022.151249_bib0006","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJMra1515442","article-title":"Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting","volume":"374","author":"Navari","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.soncn.2022.151249_bib0007","article-title":"Chemotherapy-induced nausea and vomiting: pathogenesis, recommendations, and new trends","volume":"26","author":"Gupta","year":"2021","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.soncn.2022.151249_bib0008","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fphar.2017.00019","article-title":"Delayed chemotherapy-induced nausea and vomiting: pathogenesis, incidence, and current management","volume":"8","author":"Rapoport","year":"2017","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.soncn.2022.151249_bib0009","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/1756283X15618131","article-title":"Nausea: a review of pathophysiology and therapeutics","volume":"9","author":"Singh","year":"2016","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.soncn.2022.151249_bib0010","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fphar.2020.00329","article-title":"Patient-related risk factors for chemotherapy-induced nausea and vomiting: A systemic review","volume":"11","author":"Mosa","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.soncn.2022.151249_bib0011","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/annonc\/mdj078","article-title":"Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference","volume":"17","author":"Roila","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.soncn.2022.151249_bib0012","unstructured":"National Comprehensive Cancer Network (NCCN). Antiemesis. (version 1.2021). Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/antiemesis.pdf. Accessed October 1, 2021."},{"issue":"24","key":"10.1016\/j.soncn.2022.151249_bib0013","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1200\/JCO.20.01296","article-title":"Antiemetics: ASCO Guideline Update","volume":"38","author":"Hesketh","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2022.151249_bib0014","doi-asserted-by":"crossref","first-page":"v119","DOI":"10.1093\/annonc\/mdw270","article-title":"2016 MASCC and ESMO guideline update for the prevention of chemotherapy and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients","volume":"27","author":"Roila","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.soncn.2022.151249_bib0015","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s40425-019-0805-8","article-title":"Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors","volume":"7","author":"Das","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"4","key":"10.1016\/j.soncn.2022.151249_bib0016","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/onco.13680","article-title":"Reconsidering dexamethasone for antiemesis when combining chemotherapy and immunotherapy","volume":"26","author":"Janowitz","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.soncn.2022.151249_bib0017","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","article-title":"Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer","volume":"378","author":"Gandhi","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.soncn.2022.151249_bib0018","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","article-title":"Pembrolizumab plus chemotherapy for squamous non-small-cell lung cancer","volume":"378","author":"Paz-Ares","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.soncn.2022.151249_bib0019","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/nure.12016","article-title":"Ginger (Zingiber officinale) and chemotherapy-induced nausea and vomiting: a systematic literature review","volume":"71","author":"Marx","year":"2013","journal-title":"Nutr Rev"},{"issue":"8","key":"10.1016\/j.soncn.2022.151249_bib0020","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/ptr.6377","article-title":"The effect of ginger (Zingiber officinale) on chemotherapy-induced nausea and vomiting in breast cancer patients: A systematic literature review of randomized controlled trials","volume":"33","author":"Saneei Totmaj","year":"2019","journal-title":"Phytother Res"},{"issue":"12","key":"10.1016\/j.soncn.2022.151249_bib0021","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/j.jand.2019.06.009","article-title":"Efficacy of ginger (zingiber officinale) in ameliorating chemotherapy-induced nausea and vomiting and chemotherapy-related outcomes: a systematic review update and meta-analysis","volume":"119","author":"Crichton","year":"2019","journal-title":"J Acad Nutr Diet"},{"issue":"3","key":"10.1016\/j.soncn.2022.151249_bib0022","first-page":"194","article-title":"Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment","volume":"67","author":"Greenlee","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.soncn.2022.151249_bib0023","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13020-020-00333-x","article-title":"Efficacy of acupuncture in the prevention and treatment of chemotherapy-induced nausea and vomiting in patients with advanced cancer: a multi-center, single-blind, randomized, sham-controlled clinical research","volume":"15","author":"Li","year":"2020","journal-title":"Chin Med"},{"issue":"10","key":"10.1016\/j.soncn.2022.151249_bib0024","first-page":"7965","article-title":"The effects of acupuncture at different intervention time points on nausea and vomiting caused by cisplatin chemotherapy in patients with lung cancer","volume":"13","author":"Cheng","year":"2020","journal-title":"Int J Clin Exp Med"},{"issue":"2","key":"10.1016\/j.soncn.2022.151249_bib0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.explore.2017.10.008","article-title":"Investigating the effects of the progressive muscle relaxation-guided imagery combination on patients with cancer receiving chemotherapy treatment: a systematic review of randomized controlled trials","volume":"14","author":"Kapogiannis","year":"2018","journal-title":"Explore (NY)"},{"issue":"6","key":"10.1016\/j.soncn.2022.151249_bib0026","first-page":"462","article-title":"Effects of an integrated yoga programme on chemotherapy-induced nausea and emesis in breast cancer patients","volume":"16","author":"Raghavendra","year":"2007","journal-title":"Eur J Cancer Care"},{"issue":"9","key":"10.1016\/j.soncn.2022.151249_bib0027","first-page":"4031","article-title":"Music interventions for chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis","volume":"28","author":"Wei","year":"2020","journal-title":"Support Care Cancer"},{"issue":"4","key":"10.1016\/j.soncn.2022.151249_bib0028","doi-asserted-by":"crossref","first-page":"E217","DOI":"10.1097\/NCC.0000000000000694","article-title":"Recent advances in antiemetics","volume":"43","author":"Smith","year":"2020","journal-title":"Cancer Nurs"},{"issue":"2","key":"10.1016\/j.soncn.2022.151249_bib0029","first-page":"557","article-title":"Chemotherapy-induced nausea and vomiting (CINV) and adherence to antiemetic guidelines: results of a survey of oncology nurses","volume":"26","author":"Clark-Snow","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.soncn.2022.151249_bib0030","unstructured":"U.S. Department of Veterans Affairs. Managing chemotherapy-induced nausea and vomiting. Available at: https:\/\/www.va.gov\/WHOLEHEALTHLIBRARY\/tools\/managing-chemotherapy-induced-nausea-and-vomiting.asp#ref-16. Accessed October 8, 2021."},{"issue":"1","key":"10.1016\/j.soncn.2022.151249_bib0031","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1188\/15.CJON.38-40","article-title":"A nurse-led evidence-based practice project to monitor and improve the management of chemotherapy-induced nausea and vomiting","volume":"19","author":"Underhill","year":"2015","journal-title":"Clin J Oncol Nurs"}],"container-title":["Seminars in Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074920812200002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074920812200002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:37:43Z","timestamp":1760081863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074920812200002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S074920812200002X"],"URL":"https:\/\/doi.org\/10.1016\/j.soncn.2022.151249","relation":{},"ISSN":["0749-2081"],"issn-type":[{"value":"0749-2081","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Updates in Nausea and Vomiting","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soncn.2022.151249","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151249"}}